Revenue

Fujifilm's first purpose-built cinema camera earns prestigious IMAX certification, poised to shake up the high-end market and empower more filmmakers.

A new FDA-cleared device, born from a doctor's personal struggle with epilepsy, aims to prevent seizure injuries and is now widely accessible.

Machina Medical's novel hydrogel barrier, MFUSE, gains FDA clearance, promising to control severe bleeding in seconds and disrupt the hemostasis market.

A new partnership promises to unlock thousands of discounted private jet flights by automating listings, boosting efficiency for operators and access for travelers.

Amid rising threats, the U.S. Health Department is investing in intelligence-driven cybersecurity to protect critical health systems and patient data.

An $80,000 ad spend drove nearly $1 million in ticket sales, proving a powerful new marketing model for independent movie theaters across North America.

A new strategic alliance aims to overcome manufacturing hurdles and accelerate the delivery of potentially life-changing gene therapies for genetic blindness.

Karmak rolls out its powerful Fusion 3.69 update, a refreshed brand, and new leadership, signaling a major strategic push in commercial transport tech.

Corgan promotes human-behavior expert Emily Strain to lead its Workplace Interiors, a strategic move signaling a new era for office design in a hybrid world.

An investor law firm is investigating IBM's $31 per share offer for Confluent, questioning if the price shortchanges shareholders of the data-streaming giant.

A new partnership integrates advanced imaging and ablation tech, aiming to revolutionize pain treatment as procedures shift from hospitals to clinics.

A new study reveals South Koreans are willing to pay for green logistics, making the costly shift to hydrogen fuel cell trucks a socially profitable investment.

A new AI-driven platform from CAS aims to democratize complex IP research, making high-stakes patent analysis accessible to entire organizations.

The global CRO is acquiring specialized firm Catalyst Clinical Research, aiming to dominate the booming oncology trial market. But can it navigate the risks?

Prime Capital Financial acquires Bradshaw Rogers, adding $600M AUM and bolstering its new tax advisory practice while expanding its footprint in the Carolinas.

With backing from Joe Burrow and Left Lane Capital, Ultra is tapping into the 'Zyndemic' with a clean, science-backed alternative for guilt-free focus.

77% of Americans take supplements, but most are wasted. A new company claims its science can deliver nutrients up to 149x more effectively.

For 10 years, McKesson's QCDR has helped oncologists navigate MIPS. Now, new measures aim to elevate patient care and prove the value of treatment.

With its new podcast season, Wealthspire joins a movement where wealth management is about more than money—it's about legacy, impact, and values.

Centrical's new AI Role-Play platform offers realistic practice to boost employee skills, promising to slash training time and improve key business metrics.